Dexmedetomidine as an adjuvant analgesic for intractable cancer pain

Journal of Palliative Medicine

Volumn 14, Issue 3, 2011, Pages 371-373

  Roberts, Seth B ^a   Wozencraft, Colin P ^a   Coyne, Patrick J ^a   Smith, Thomas J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CLONIDINE; DEXMEDETOMIDINE; HYDROMORPHONE; METHADONE; MORPHINE SULFATE; OXYCODONE;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER PAIN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INFUSION PUMP; INTRACTABLE PAIN; MYOCLONUS; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA;

ANALGESICS, NON-NARCOTIC; CHEMOTHERAPY, ADJUVANT; DEXMEDETOMIDINE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; PAIN, INTRACTABLE;

EID: 79952303264     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.0235     Document Type: Article

References (15)

1. Gerlach AT, Murphy CV, Dasta JF: An updated focused review of dexmedetomidine in adults. Ann Pharmacother 2009;43:2064-2074.
2. Haselman MA: Dexmedetomidine: A useful adjunct to consider in some high-risk situations. AANA J 2008;76:335-339.
3. Gerlach AT, Dasta JF: Dexmedetomidine: An updated review. Ann Pharmacother 2007;41:245-252.
4. Jackson KC III, Wohlt P, Fine PG: Dexmedetomidine: A novel analgesic with palliative medicine potential. J Pain Palliat Care Pharmacother 2006;20:23-27. (Pubitemid 43962740)
5. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007;298:2644-2653. (Pubitemid 350254956)
6. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared with Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009;301:489-499.
7. Muller S, Borowics SM, Fortis EA, Stefani LC, Soares G, Maguilnik I, Breyer HP, Hidalgo MP, Caumo W: Clinical efficacy of dexmedetomidine alone is less than propofol for conscious sedation during ERCP. Gastrointest Endosc 2008;67:651-659. (Pubitemid 351419206)
8. Bekker A, Sturaitis M, Bloom M, Moric M, Golfinos J, Parker E, Babu R, Pitti A: The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg 2008;107:1340-1347.
9. Baddigam K, Russo P, Russo J, Tobias JD: Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005;20:118-123. (Pubitemid 43093903)
10. Sadhasivam S, Boat A, Mahmoud M: Comparison of patientcontrolled analgesia with and without dexmedetomidine following spine surgery in children. J Clin Anesth 2009; 21:493-501.
11. Wallace S, Mecklenburg B, Hanling S: Profound reduction in sedation and analgesic requirements using extended dexmedetomidine infusions in a patient with an open abdomen. Mil Med 2009;174:1228-1230.
12. Barletta JF, Miedema SL, Wiseman D, Heiser JC, McAllen KJ: Impact of dexmedetomidine on analgesic requirements in patients after cardiac surgery in a fast-track recovery room setting. Pharmacotherapy 2009;29:1427-1432.
13. Zhang X, Schmidt U, Wain JC, Bigatello L: Bradycardia leading to asystole during dexmedetomidine infusion in an 18-year-old double-lung transplant recipient. J.Clin Anesth 2010;22:45-49.
14. Gerlach AT, Murphy CV: Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: Case report and review of the literature. Pharmacotherapy 2009; 29:1492.
15. Soares LG, Naylor C, Martins MA, Peixoto G: Dexmedetomidine: A new option for intractable distress in the dying. J Pain Symptom Manage 2002;24:6-8.